SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053292
Filing Date
2020-11-12
Accepted
2020-11-12 07:34:44
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sdgr-10q_20200930.htm 10-Q 3919996
2 EX-10.1 sdgr-ex101_11.htm EX-10.1 111429
3 EX-10.2 sdgr-ex102_8.htm EX-10.2 121391
4 EX-31.1 sdgr-ex311_7.htm EX-31.1 15569
5 EX-31.2 sdgr-ex312_6.htm EX-31.2 15575
6 EX-32.1 sdgr-ex321_9.htm EX-32.1 5573
7 EX-32.2 sdgr-ex322_10.htm EX-32.2 5711
  Complete submission text file 0001564590-20-053292.txt   10019447

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT sdgr-20200930.xml EX-101.INS 1792788
9 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20200930.xsd EX-101.SCH 58143
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sdgr-20200930_cal.xml EX-101.CAL 52667
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdgr-20200930_def.xml EX-101.DEF 221335
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20200930_lab.xml EX-101.LAB 433045
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20200930_pre.xml EX-101.PRE 339073
Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39206 | Film No.: 201303387
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences